F104 Chemical Peeling in 2024: An International Perspective
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Chemical peeling has a proven track record of safety and effectiveness across a variety of medical and cosmetic indications, and may contribute to favorable patient outcomes. Learn from our expert, international faculty on the basics of chemical peeling, including patient preparation, clinical endpoints, peels for melasma, medium depth peels, and recognizing and managing complications. For the advanced peeler, we dive into nuances of deep chemical peeling, periorbital peeling as well as peeling the body.
LEARNING OBJECTIVES
Assess aesthetic and medical indications most appropriate for superficial, medium and deep chemical peeling
Diagnose and manage complications of chemical peeling
SCHEDULE
8:00 PM
Welcome and Introductions
Seaver Soon, MD, FAAD, Harold J. Brody, MD, FAAD
8:06 PM
Chemical peel applicators: do you paint like I paint?
Carlos G Wambier, MD, IFAAD
8:19 PM
Skin visualization in chemical peeling
Fotini Bageorgou, MD, IFAAD
8:32 PM
Chemical peeling for acne scars
Jaishree Sharad, DDV, MBBS, MD, IFAAD
8:45 PM
Peels for melasma
Felipe Ribeiro da Silva, MD
8:58 PM
Preventing post-inflammatory hyperpigmentation in medium depth peels
Doris M Hexsel, MD, IFAAD
9:11 PM
What you can offer to your patient, when everything else fails or is irrelevant?
Marina Landau, MD, IFAAD
9:24 PM
Perioral phenol-croton oil chemical peeling
J. Barton Sterling, MD, FAAD
9:37 PM
Deep peel complications
Jennifer M Rullan, MD, FAAD
9:50 PM
Panel Discussion
SPEAKERS
Fotini Bageorgou, MD, IFAAD
Harold J. Brody, MD, FAAD
Doris M Hexsel, MD, IFAAD
Marina Landau, MD, IFAAD
Felipe Ribeiro da Silva, MD
Jennifer M Rullan, MD, FAAD
Jaishree Sharad, DDV, MBBS, MD, IFAAD
Seaver Soon, MD, FAAD
J. Barton Sterling, MD, FAAD
Carlos G Wambier, MD, IFAAD
SPEAKER DISCLOSURES
Fotini Bageorgou, MD, IFAAD
No financial relationships exist with ineligible companies.
Harold J. Brody, MD, FAAD
No financial relationships exist with ineligible companies.
Doris M Hexsel, MD, IFAAD
No financial relationships exist with ineligible companies.
Marina Landau, MD, IFAAD
No financial relationships exist with ineligible companies.
Felipe Ribeiro da Silva, MD
No financial relationships exist with ineligible companies.
Jennifer M Rullan, MD, FAAD
No financial relationships exist with ineligible companies.
Jaishree Sharad, DDV, MBBS, MD, IFAAD
No financial relationships exist with ineligible companies.
Seaver Soon, MD, FAAD
Merz Aesthetics – Advisory Board(Honoraria); Sanofi/Regeneron – Speaker(Honoraria); TEOXANE Laboratories – Speaker/Faculty Education(Honoraria);
J. Barton Sterling, MD, FAAD
No financial relationships exist with ineligible companies.
Carlos G Wambier, MD, IFAAD
Allergan, Inc. – Advisory Board(Fees); Applied Biology – Advisory Board(Fees); ChemistryRx – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Cynosure – Speaker/Faculty Education(Fees); Daniel Alain – Advisory Board(Fees); Eli Lilly – Investigator(Grants/Research Funding); Galderma Brasil Ltda – Speaker(Fees); Incyte – Advisory Board(Fees); Pfizer Inc. – Investigator(Grants/Research Funding), Speaker(Fees); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); UCB – Investigator(Grants/Research Funding); Wambier Dermatologics, LLC – Founder(Other Financial Benefit); Young Pharmaceuticals – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights);